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Comparison of dissolution testing 
methods for the 25 mg dapivirine
vaginal ring
Background
Objectives
Methods
Results & Discussion
The historical shaking incubator method for in vitro release testing of
the 25 mg dapivirine vaginal ring offers increased practicality and
reproducibility compared with the USP rotating paddle method. The
rotating paddle method suffers significant evaporative loss of the
release medium, which needs to be accounted for in order to
accurately determine release values.
Key points
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In vitro release testing of vaginal rings – including the 25 mg
dapivirine ring – has historically been performed using non-
compendial shaking incubator methods. Here, we tested in
vitro release of the 25 mg dapivirine ring using an Apparatus 2
Rotating Paddle dissolution apparatus method, commonly
used for compendial dissolution testing of oral dosage forms.
Significant loss of release medium due to evaporation was
observed with the rotating paddle method. By accurately
compensating for volume loss, dapivirine release profiles for
the 25 mg rings were similar for the rotating paddle and
shaking incubator methods.
There is a long history of using non-compendial, methods for in vitro release
testing of vaginal rings. Typically, individual rings in a sealed glass flask
containing a defined volume of release medium are placed in a temperature-
controlled shaking incubator. Flasks are regularly and periodically sampled
(usually with complete medium replacement) over weeks or months. The
benefits of this method include a facile experimental set-up, no concerns over
evaporation of the release media due to use of a sealed flask, easy sampling
and media replacement procedures, and accurate control of temperature and
rotational speed. This method also allows use of relatively large volumes of
release media which may be necessary to maintain sink conditions throughout
the experiment.
o 25 mg DPV, matrix-type, silicone elastomer vaginal rings were supplied by
QPharma (Malmö, Sweden).
o Rotating paddle dissolution testing in both IPA+water (1:1 v/v; 300 mL) and
SVF+Tween (300 mL) was performed using a ERWEKA DT 126 Light
Dissolution Tester (50 rpm, 37°C).
o Shaking incubator dissolution testing of the rings was also performed, as
described in the literature (100/200 mL, 37°C, 25 mm orbital diameter).
o DPV concentrations were quantified by HPLC.
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Here, we investigate use of a rotating paddle type dissolution apparatus for in
vitro release testing of rings. Specifically, the objectives of the study were:
o To assess in vitro release of 25 mg dapivirine (DPV) ring into two common
release media – isopropanol (IPA)+water and simulated vaginal fluid
modified with 0.2% w/v Tween 80 (SVF+Tween) – using an Apparatus 2
Rotating Paddle dissolution apparatus (37 °C / 50 rpm / 300 mL medium)
(Figs. 1A & 1B)
o To assess in vitro release of the 25 mg DPV ring into IPA+water and
SVF+Tween – using the shaking incubator method (37 °C / 60 rpm / 100 or
200 mL medium) (Fig. 1C)
o To compare the release data obtained with the two methods
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Fig. 1. Apparatus 2 rotating
paddle dissolution apparatus
containing 25 mg DPV ring in 300
mL SVF+Tween (A) and
IPA+water (B). C – Shaking
incubator method for in vitro
release testing of 25 mg DPV
rings.
Fig. 2: 28-day in vitro DPV
release profiles for 25 mg DPV
vaginal rings. A – daily release
into IPA+water; B – cumulative
release into IPA+water; C – daily
release into SVF+Tween; D –
cumulative release into
SVF+Tween.
Test 
method
Release   
medium
Volume 
adjust?
Mean release 
rate (µg/day1/2) r
2 value
RP IPA+water No 2823 0.9983
RP IPA+water Yes 2369 0.9977
SI IPA+water – 2423 0.9982
RP SVF+Tween No 1121 0.9987
RP SVF+Tween Yes 1080 0.9988
SI SVF+Tween – 1082 0.9947
Table 1. Comparison of mean release rates and
correlation coefficients (cumulative release vs. root time) for 25
mg DPV ring into IPA+water and SVF+Tween using USP
Apparatus 2 (rotating paddle (RP), with and without adjustment
for volume loss) and shaking incubator (SI) method.
Daily and cumulative release vs. time profiles for 25 mg
DPV rings into IPA+water and SVF+Tween are presented
in Fig. 2, for both the rotating paddle method – with and
without adjustment for volume loss associated with
evaporation of the release medium – and the shaking
incubator method. Summary release data is presented in
Table 1. Release into IPA+water was greater compared
with release into SVF+Tween, reflecting differences in
the solvating power of the media. Loss of release
medium caused by evaporation was a serious issue with
the rotating paddle method, particularly for the IPA+water
medium. Approx. 26 mL/day (8.6% of the total volume) of
the IPA+water release was lost to evaporation, compared
with ~6 mL/day (2% of the total volume) for the SVF+
Tween medium. By accurately measuring the volume of
medium remaining in the flasks at each sampling
timepoint, compensation for volume loss could be made
such that release closely matched that measured using
the shaking incubator method (Fig. 2, Table 1). However,
having to compensate for volume loss at each sampling
timepoint significantly reduces the practicality of the
rotating paddle method. Impracticalities aside, the two
methods produce similar in vitro release profiles.
